Chongqing Lummy Pharmaceutical News

Laimei Pharmaceuticals: Announcement on preparation for asset impairment accrued for the first quarter of 2024

Apr 23 12:00 ET

Laimei Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

Apr 12 12:00 ET

Laimei Pharmaceutical: Legal Opinion of Beijing Zhonglun Law Firm on the 2023 Annual General Meeting of Shareholders of Chongqing Laimei Pharmaceutical Co., Ltd.

Apr 12 12:00 ET

Laimei Pharmaceuticals: Announcement on the lawsuit filed by a wholly-owned subsidiary

Apr 8 12:00 ET

Laimei Pharmaceuticals: Guojin Securities's regular on-site inspection report on continued supervision of Laimei Pharmaceuticals

Mar 29 12:00 ET

Laimei Pharmaceuticals: Guojin Securities\'s 2023 follow-up report on Laimei Pharmaceuticals

Mar 29 12:00 ET

Laimei Pharmaceutical: Announcement on the holding subsidiary obtaining a medical device registration certificate

Mar 25 12:00 ET

Laimei Pharmaceuticals: Internal Control System

Mar 22 12:00 ET

Laimei Pharmaceuticals: 2023 Internal Control Evaluation Report

Mar 22 12:00 ET

Laimei Pharmaceuticals: Announcement on preparation for impairment of assets accrued for 2023

Mar 22 12:00 ET

Laimei Pharmaceutical: Notice on requesting the shareholders' meeting to authorize the board of directors to issue shares to specific targets through simplified procedures

Mar 22 12:00 ET

Laimei Pharmaceutical: Notice on convening the 2023 Annual General Meeting of Shareholders

Mar 22 12:00 ET

Laimei Pharmaceuticals: 2023 Financial Results Report

Mar 22 12:00 ET

Laimei Pharmaceutical: Special instructions on the company\'s intention not to distribute profits in 2023

Mar 22 12:00 ET

Laimei Pharmaceuticals: Notice on Obtaining Approval Notice for Drug Supplemental Applications

Mar 14 12:00 ET

Laimei Pharmaceutical: Announcement on the acceptance of lawsuits by holding subsidiaries and matters involved in litigation

Mar 6 11:00 ET

Laimei Pharmaceutical: Announcement on the Wholly-owned Subsidiary Obtaining a Notice of Approval of the Application for the Marketing of Chemical Ingredients

Mar 1 11:00 ET

Laimei Pharmaceutical: Announcement on the progress of the holding subsidiary\'s capital increase agreement and filing of lawsuits

Dec 29, 2023 11:00 ET

Laimei Pharmaceutical: Legal Opinion of Beijing Zhonglun Law Firm on the Third Extraordinary General Meeting of Shareholders of Chongqing Laimei Pharmaceutical Co., Ltd. in 2023

Dec 28, 2023 11:00 ET

Laimei Pharmaceutical: Announcement of Resolutions of the Third Extraordinary General Meeting of Shareholders in 2023

Dec 28, 2023 11:00 ET